Palisade Bio (PALI) Net Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | -41.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.42% |
| Dec 31, 2025 | 334.48% |
| Sep 30, 2025 | -26.43% |
| Jun 30, 2025 | -2.90% |
| Mar 31, 2025 | 12.37% |
| Dec 31, 2024 | 35.60% |
| Sep 30, 2024 | -62.40% |
| Jun 30, 2024 | -81.28% |
| Mar 31, 2024 | -127.64% |
| Dec 31, 2023 | -323.19% |
| Sep 30, 2023 | -12.41% |
| Jun 30, 2023 | 34.72% |
| Mar 31, 2023 | -42.92% |
| Dec 31, 2022 | 9.84% |
| Sep 30, 2022 | 21.47% |
| Jun 30, 2022 | 1.14% |
| Mar 31, 2022 | -29.26% |
| Dec 31, 2021 | -313.00% |
| Sep 30, 2021 | 45.38% |
| Jun 30, 2021 | 86.31% |
| Mar 31, 2021 | -26.66% |
| Dec 31, 2020 | 74.85% |
| Sep 30, 2020 | -31.86% |
| Jun 30, 2020 | -10.75% |
| Mar 31, 2020 | 50.35% |
| Dec 31, 2019 | -30.64% |
| Sep 30, 2019 | 42.95% |
| Jun 30, 2019 | -35.56% |
| Mar 31, 2019 | -37.75% |
| Dec 31, 2018 | 26.12% |
| Sep 30, 2018 | -32.03% |
| Jun 30, 2018 | 18.99% |
| Mar 31, 2018 | 41.58% |
| Dec 31, 2017 | -83.36% |
| Sep 30, 2017 | 40.91% |
| Jun 30, 2017 | -18.26% |
| Mar 31, 2017 | -63.20% |
| Dec 31, 2016 | 177.92% |
| Sep 30, 2016 | -44.91% |
| Jun 30, 2016 | 63.23% |
| Mar 31, 2016 | -17.72% |
| Dec 31, 2015 | -51.28% |
| Sep 30, 2015 | -15.13% |
| Jun 30, 2015 | -23.82% |
| Mar 31, 2015 | -27.27% |
| Dec 31, 2014 | 32.22% |
| Sep 30, 2014 | -19.09% |
| Jun 30, 2014 | -8.96% |
| Mar 31, 2014 | 59.99% |
| Dec 31, 2013 | 29.87% |
| Sep 30, 2013 | 60.65% |